EP 1194159 A1 20020410 - USE OF INTERLEUKIN-6 IN TREATMENT OF OBESITY AND/OR OBESITY ASSOCIATED DISORDERS
Title (en)
USE OF INTERLEUKIN-6 IN TREATMENT OF OBESITY AND/OR OBESITY ASSOCIATED DISORDERS
Title (de)
VERWENDUNG VON INTERLEUKIN-6 ZUR BEHANDLUNG VON FETTLEIBIGHEIT UND/ODER FETTLEIBIGKEIT ASSOZIIERTEN STöRUNGEN
Title (fr)
UTILISATION DE L'INTERLEUKINE-6 DANS LE TRAITEMENT DE L'OBESITE ET/OU DES TROUBLES ASSOCIES
Publication
Application
Priority
- SE 0001491 W 20000713
- SE 9902680 A 19990713
- SE 9904424 A 19991203
Abstract (en)
[origin: WO0103725A1] Use of a substance that upon administration to a patient will lead to an increased level of an interleukin-6 (IL-6) receptor agonist, preferably IL-6, for the production of a medicinal product for treatment of obesity and/or obesity associated disorders is disclosed. Also a method for treatment of obesity and/or obesity associated disorders wherein a pharmaceutically effective amount of a substance that upon administration to a patient will lead to an increased level of an interleukin-6 receptor agonist is disclosed.
IPC 1-7
IPC 8 full level
A61K 38/17 (2006.01); A61P 3/04 (2006.01); A61P 3/06 (2006.01)
CPC (source: EP)
A61K 38/204 (2013.01); A61K 38/2264 (2013.01); A61P 3/04 (2017.12); A61P 3/06 (2017.12)
Citation (search report)
See references of WO 0103725A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0103725 A1 20010118; AU 6330300 A 20010130; EP 1194159 A1 20020410; SE 9904424 D0 19991203
DOCDB simple family (application)
SE 0001491 W 20000713; AU 6330300 A 20000713; EP 00950167 A 20000713; SE 9904424 A 19991203